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Porphyromonas gingivalis LPS and 
CpG differentially regulate IL-10 
competency and frequencies of mouse 
B10 cells
signaling and co-stimulatory molecules on B10 activity during innate and 
adaptive immune responses are not fully understood. Objective: This study is 
to determine the effects of P. gingivalis LPS and CpG on B10 cell expansion and 
IL-10 competency in vitro. Material and Methods: Spleen B cells were isolated 
P. gingivalis immunization. 
B cells were cultured for 48 hours under the following conditions: CD40L, 
CD40L+LPS, CD40L+CpG, and CD40L+LPS+CpG in the presence or absence of 
P. gingivalis. Percentages of CD1dhiCD5+
cytometry. IL-10 mRNA expression and secreted IL-10 were measured by real-
time quantitative PCR and by ELISA respectively. Results: P. gingivalis LPS plus 
10 levels in both immunized and non-immunized mice B cells in the presence 
or absence of P. gingivalis, compared with control group. Secreted IL-10 levels 
treatment group in the absence of P. gingivalis
decreased CD1dhiCD5+ B cell percentages, but greatly elevated secreted IL-
10 levels in immunized and non-immunized mice B cells in the absence of P. 
gingivalis, compared with CD40L treatment group. Conclusions: P. gingivalis 
LPS and CpG differentially enhance IL-10 secretion and expansion of mouse B10 
cells during innate and adaptive immune responses.
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Introduction
IL-10 expressing regulatory B cells (B10) is a 
humans27. B10 cell down-regulates autoimmune 
IL-10 expression, playing crucial regulatory roles in 
innate and adaptive immunity27. Though mouse B10 
they have been found to be predominantly enriched 
in spleen CD1dhighCD5+ B cells27.
recognition receptors, are specialized transmembrane 
proteins that mediate innate immunity through 
detecting common structures of many microbial 
species such as bacterial lipopolysaccharides (LPS) 
or viral nucleic acids17,25. Upon recognition of a 
pathogen, TLRs initiate a signaling cascade that 
8,21. 
Porphyromonas gingivalis (P. gingivalis) LPS has been 
shown to be able to activate both TLR2 and TLR4 
due to its unique structure and function2,6, and CpG 
responses9,16.
Interaction between CD40 Ligand (CD40L) 
and CD40 plays an important role in the initiation 
and progression of cellular and humoral adaptive 
immunity15. The activation of CD40 on B cells by CD40L 
is crucial for T cell-dependent B cell proliferation, 
differentiation, and antibody isotype switching11,13,14.
Recent studies demonstrated that culturing 
spleen B cells with LPS or CD40L for 48 h induced 
10 production in B cells than control in vitro20. LPS 
stimulation of spleen B cells for 24 h induced more 
IL-10 than unstimulated cells28. Spleen B cells with a 
CD1dhighCD21+CD23- MZ phenotype can produce IL-10 
autoimmune disease30. However, despite all these 
stimulatory molecules, such as CD40L, on B10 activity 
during innate and adaptive immune responses are 
not clearly understood. Furthermore, there is limited 
information on the role of B10 cells during immune 
responses to oral diseases, such as periodontal 
disease, when encountering oral pathogens and their 
derivatives. In the present study, spleen B cells from P. 
gingivalis non-immunized and immunized mice were 
co-stimulated with TLR4, TLR9, and CD40 signals to 
investigate their effects on B10 cell expansion and 
IL-10 competency in vitro.
Material and Methods
P. gingivalis
P. gingivalis (strain ATCC 33277) were grown on 
anaerobic blood agar plates (NHK agar, Northeast 
Laboratory, Waterville, ME, U.S.A.) in an anaerobic 
chamber with 85% N2, 5% H2, and 10% CO2. Single 
colony of P. gingivalis was isolated from the plate 
and grown in ATCC Medium 2722. After incubation at 
37°C for 4 d, bacteria number in culture medium was 
determined by reading optical density values using 
spectrophotometer and comparing them with a curve 
derived from a standard plate count. Bacteria were 
for 30 min at room temperature, then washed three 
times with sterile phosphate-buffered saline (PBS) and 
resuspended in PBS at the concentration of 5×108/mL.
Animals
randomly divided into four groups. Group 1 and 2 
were set as non-immunized mice groups in which 
Group 3 and 4 were set as immunized mice groups 
and mice were immunized by 1×108 P. gingivalis 
intraperitoneal injection at day 0, then followed by 
1×107 P. gingivalis injection at day 7 to enhance 
isolation at day 10. All mice used in the study were 
maintained under pathogen-free conditions in laminar 
by the Institutional Animal Care and Use Committee 
of the Forsyth Institute.
B cell isolation
Mice were euthanized in CO2 chamber and spleens 
were harvested. Single splenic cells were yielded by 
Ammonium-Chloride-Potassium (ACK) lysis buffer 
(Life Technologies, Carlsbad, CA, USA), splenic cells 
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Cell Strainers. Then non-B cells were magnetically 
suspensions were incubated with biotin-conjugated 
monoclonal antibodies against non-B cell surface 
Ter119) at 4°C for 10 min followed by incubation 
with magnetic microbeads conjugated anti-biotin 
antibodies at 4°C for 15 min. Magnetically labeled 
cells were then depleted by passing through LD 
columns (Miltenyi Biotec, Cambridge, MA, USA) under 
(Miltenyi Biotec, Cambridge, MA, USA). Unlabeled 
cells that passed through LD column were collected 
(contained >98.5% CD19+ cells).
B cell culture
B cell number was counted by hemacytometer. 
Each 1×106
IMDM+GlutaMAXTM (Life Technologies, Carlsbad, CA, 
USA) complete medium (contains 10% FCS, 100 U/mL 
penicillin, 100 mg/mL streptomycin, 2 mM L-glutamine, 
plates under the following conditions: control, CD40L, 
CD40L+LPS, CD40L+CpG, or CD40L+LPS+CpG in the 
P. gingivalis. Final 
concentrations of these stimulants were as follows: 
P. gingivalis LPS (Invivogen, San Diego, CA, USA, 10 
P. gingivalis (5×106/1×106 
cells). P. gingivalis LPS was used as TLR4 agonist and 
mouse CpG-DNA(5’-TCCATGACGTTCCTGATGCT -3’) 
was used as TLR9 agonist. B cells cultured without 
stimulation were used as control. Cells were cultured 
2 for 48 
to determine CD1dhighCD5+ B cell percentages and 
remaining cells were used to determine IL-10 mRNA 
expression levels. Culture supernatant was used for 
secreted IL-10 levels measurement.
CD1dhighCD5+ B cells percentages determination
B cells were washed with PBS and Fc receptors 
TM 
(BioLegend, San Diego, CA, USA) on ice for 10 min, 
then followed by incubation with PE anti-mouse CD1d 
(BioLegend, San Diego, CA, USA) and Alexa Fluor 647 
(BioLegend, San Diego, CA, USA) on ice for 30 m using 
predetermined optimal concentrations. Then, all cells 
San Jose, CA, USA) and data were analyzed by 
FlowJo v10 software. For each sample, the same gate 
was applied to the other samples to determine their 
CD1dhighCD5+ B cell percentages. Since mouse B10 
cells has been found to be predominantly enriched 
in spleen CD1dhighCD5+ B cells, CD1dhighCD5+ B cell 
percentage is considered as the proportional indicator 
of B10 cell percentage.
IL-10 mRNA expression measurement
RNA Mini Kit (Life Technologies, Carlsbad, CA, USA) 
following the manufacturer’s instructions. Isolated 
mRNA was then reverse transcribed to cDNA using 
the SuperScript™ II Reverse Transcriptase system 
(Invitrogen, San Diego, CA, USA) in the presence 
of random primers following the manufacturer’s 
instructions. Then, real-time quantitative PCR (RT-
Diagnostics, Indianapolis, IN, USA) and LightCycler 
480 Instrument (Roche Diagnostics, Indianapolis, IN, 
and measured in duplicate. 250 nM pre-designed 
IL-10 (Invitrogen, San Diego, CA, USA) or GAPDH 
primers (Sigma, St. Louis, MO, USA) were used 
and their sequences were as follows: IL-10, forward 
5’-GACCAGCTGGACAACATACTGCTAA-3’ and reverse 
5’-GATAAGGCTTGGCAACCCAAGTAA-3’; GAPDH, 
forward 5’-CCCCAGCAAGGACACTGAGCAA-3’ and 
reverse 5’- GTGGGTGCAGCGAACTTTATTGATG-3’. RT-
qPCR conditions were: 95°C for 10 min, followed by 
45 cycles of 95°C for 10 s, 55°C for 15 s, and 72°C 
expression level were presented as fold changes 
relative to GAPDH reference.
Secreted IL-10 level measurement
Secreted IL-10 levels in the cultured supernatant 
were measured by Mouse IL-10 ELISA MAX Standard 
Kit (BioLegend, San Diego, CA, USA) following the 
manufacturer’s manual. All samples were immediately 
1:1 diluted prior to measure and measured in 
duplicate. Absorbance values were read by Synergy 
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at 450 nm and IL-10 concentrations were calculated 
according to standard curve and dilution ratio.
Statistical analysis
All quantitative data were expressed as means±SD. 
Statistical analysis was performed using Student’s 
t-test for comparisons of two groups. Statistical 
Results
Non-immunized mice CD1dhighCD5+ B cell 
expansion with CD40L, LPS, and CpG 
treatment with/without P. gingivalis co-
stimulation
B cells separated from non-immunized mice 
splenocytes were cultured for 48 h under multiple 
conditions including CD40L, CD40L+LPS, CD40L+CpG, 
and CD40L+LPS+CpG (Figure 1a); P. gingivalis, 
P. gingivalis+CD40L, P. gingivalis+CD40L+LPS, 
P.g+CD40L+CpG, and P. gingivalis+CD40L+LPS+CpG 
(Figure 1b). The percentage of CD1dhighCD5+ B cell 
each group. Compared with non-treatment control 
group, CD40L significantly induced CD1dhighCD5+ 
B cell expansion and CD40L+LPS had similar 
significant induction; however, additional CpG 
highCD5+ 
B cell expansion with or without LPS (Figure 1c). 
CD1dhighCD5+
P. gingivalis treatment only, 
comparing with non-treatment control group; and the 
induction by CD40L and CD40L+LPS or suppression 
by additional CpG were not affected by additional P. 
gingivalis
or without P. gingivalis treatment on non-immunized 
mice splenocyte B cells, CD40L and CD40L+LPS 
highCD5+ B cell expansion 
1).
Immunized mice CD1dhighCD5+ B cell expansion 
with CD40L, LPS, and CpG treatment with/
without P. gingivalis co-stimulation
B cells separated from immunized mice splenocytes 
were cultured for 48 h under the same conditions 
(Figures 2a, 2b). Compared with non-treatment control 
highCD5+ B cell 
expansion and additional LPS slightly reduced this 
induction; also, additional CpG largely suppressed 
CD40L-induced CD1dhighCD5+ B cell expansion with 
or without LPS (Figure 2c). For immunized mice, 
CD1dhighCD5+
P. gingivalis treatment alone, 
comparing with non-treatment control group; and the 
induction by CD40L or suppression by additional CpG 
were not affected by additional P. gingivalis treatment. 
However, additional LPS inhibition effect on CD40L 
induction was vanished with P. gingivalis treatment 
(Figure 2d) comparing with no P. gingivalis treatment 
(Figure 2c) in immunized mice B cells (Table 2). 
These results indicated that B cells from P. gingivalis 
immunized mice had partial similar responses for 
CD40L, CD40L+LPS, and CD40L+CpG treatment with 
or without P. gingivalis co-stimulation, compared with 
B cells from non-immunized mice. Other than that, 
CD1dhighCD5+ B cell without P. gingivalis (Figure 2c), 
but had no effect on non-immunized CD1dhighCD5+ B 
cell (Figure 1c); also, compared with P. gingivalis only 
treatment group, CD40L+P. gingivalis treatment had 
highCD5+ 
in non-immunized CD1dhighCD5+ B cell (Figure 1d).
IL-10 mRNA levels in B cells from non-
immunized and immunized mice with CD40L, 
LPS, and CpG treatment with/without P. 
gingivalis co-stimulation
IL-10 mRNA levels were measured and 
analyzed by RT-qPCR in cultured B cells separated 
from non-immunized mice (Figures 3a and 3b) 
and immunized mice (Figures 3c and 3d) with 
multiple treatments including CD40L, CD40L+LPS, 
CD40L+CpG, and CD40L+LPS+CpG (Figures 3a 
and 3c); P. gingivalis, P. gingivalis+CD40L, P. 
gingivalis+CD40L+LPS, P. gingivalis+CD40L+CpG, 
and P. gingivalis+CD40L+LPS+CpG (Figures 3b and 
3d). Comparing with non-treatment control group, 
and additional LPS enhanced this increase in B cells 
from non-immunized mice (Figure 3a), but not from 
immunized mice (Figure 3c). However, additional 
CpG largely increased IL-10 mRNA expression 
compared with CD40L treatment with or without LPS 
in B cells from both types of mice (Figures 3a and 
3c). P. gingivalis
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Figure 1- P. gingivalis 
g/mL), 
CD40L (1 g/mL)+P. gingivalis LPS (10 g/mL), CD40L(1 g/mL)+CpG (10 M), and CD40L (1 g/mL)+P. gingivalis LPS (10 g/mL)+CpG 
(10 P. gingivalis (5×106 per 1×106 cells). CD1highCD5+
P. gingivalis P. gingivalis
staining). The percentage of CD1highCD5+
P. gingivalis P. gingivalis
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IL-10 mRNA expression, and this enhancement 
CD40L+LPS, CD40L+CpG, and CD40L+LPS+CpG in 
B cells from both types of mice (Figures 3b and 3d). 
P. gingivalis treatment; however, these additional 
combinations suppressed the induction of IL-10 mRNA 
expression caused by P. gingivalis.
Secreted IL-10 levels in B cells from non-
immunized and immunized mice with CD40L, 
LPS, and CpG treatment with/without P. 
gingivalis co-stimulation
Secreted IL-10 levels were measured and 
analyzed by ELISA from supernatant of cultured B 
cells separated from non-immunized mice (Figure 4a 
and 4b) and immunized mice (Figures 4c and 4d). 
Comparing with non-treatment control group, CD40L 
non-immunized mice only and additional LPS enhanced 
this increase in B cells from both type of mice (Figures 
4a and 4c). Also, additional CpG largely increased 
IL-10 secretion compared with CD40L treatment 
with or without LPS in B cells from both types of 
mice (Figures 4a and 4c). P. gingivalis stimulation 
this induction was significantly suppressed with 
additional CD40L+CpG, but additional CD40L and 
Cd40L+LPS had no impacts on this induction (Figures 
4b, 4d). These results suggested that Cd40L+LPS and 
without P. gingivalis treatment; however, P. gingivalis 
treatment significantly induced IL-10 secretion, 
additional Cd40L+LPS had no effect, and CD40L+CpG 












Table 1- Analysis of CD1dhighCD5+ P. gingivalis treatment














Table 2- Analysis of CD1dhighCD5+ P. gingivalis treatment
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Figure 2- P. gingivalis 
P. gingivalis on day 0 (1×106) and day 7 (1×105). 
g/mL), CD40L (1 g/mL)+P. 
gingivalis LPS (10 g/mL), CD40L(1 g/mL)+CpG (10 M), and CD40L (1 g/mL)+P. gingivalis LPS (10 g/mL)+CpG (10 M) in the 
P. gingivalis (5×106 per 1×106 cells). CD1highCD5+
P. gingivalis P. gingivalis
percentage of CD1highCD5+ P. gingivalis 
P. gingivalis
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Figure 3-
P. gingivalis g/mL), CD40L (1 g/mL)+P. 
gingivalis LPS (10 g/mL), CD40L (1 g/mL)+CpG (10 M), and CD40L (1 g/mL)+P. gingivalis LPS (10 g/mL)+CpG (10 M) in the 
P. gingivalis (5×106 per 1×106
P. gingivalis P. gingivalis (b) from non-immunized C57/BL6J mice, and same groups from immunized 
P. gingivalis P. gingivalis
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Figure 4- P. 
gingivalis g/mL), CD40L (1 g/mL)+P. gingivalis 
LPS (10 g/mL), CD40L (1 g/mL)+CpG (10 M), and CD40L (1 g/mL)+P. gingivalis LPS (10 g/mL)+CpG (10 M) in the absence or in 
P. gingivalis (5×106 per 1×106
P. gingivalis P. gingivalis (b) from non-immunized C57/BL6J mice, 
P. gingivalis P. gingivalis
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Discussion
IL-10 producing B10 cells play an essential role 
in immune system balance by suppressing excessive 
18,20,30
about the effects of co-stimulation by multiple TLR 
agonists and CD40 activator on B10 cells under different 
immunological conditions. In the present study, we 
investigated the changes of B10 cell population and 
IL-10 secretion by combined treatment of P. gingivalis 
LPS (TLR4 agonist), CpG (TLR9 agonist), and CD40L 
in the context of innate immunity (cells from non-
immunized mice) and adaptive immunity (cells from 
immunized mice). The results showed that P. gingivalis 
LPS enhanced IL-10 secretion by B10 cells in mice in 
vitro during innate and adaptive immune responses 
with increased CD1dhighCD5+ B cells; However, CpG was 
more effective than P. gingivalis LPS to enhance IL-10 
competency during these responses with decreased 
CD1dhighCD5+ B cells.
P. gingivalis LPS is a purified product of 
lipopolysaccharide from Gram-negative bacteria 
Porphyromonas gingivalis, which is considered as 
the main pathogen of periodontal disease3,12,26. LPS 
is the major component of Gram negative bacteria 
that activates the innate immune system4,29. However, 
P. gingivalis LPS has a unique and heterogenous 
chemical structure, which is different from traditionally 
recognized enteric bacterium-derived LPS such as E. 
coli LPS7,22,23. P. gingivalis LPS and E. coli LPS have been 
signaling pathways7 1,22. It 
was suggested that the structural heterogeneity of 
P. gingivalis lipid A contributes to the unusual innate 
host response to this LPS and its ability to interact with 
both TLR2 and TLR42,6. This may explain the difference 
of the induction effects on B10 population and IL-10 
secretion between co-stimulating P. gingivalis LPS plus 
CD40L and E. coli LPS plus CD40L in non-immunized 
mice19. In non-immunized mice without P. gingivalis 
treatment, additional P. gingivalis LPS did not further 
increase CD1dhighCD5+ B cells percentages (Figure 1c), 
(Figure 3a) and IL-10 secretion (Figure 4a) compared 
with CD40L only group. Moreover, in immunized 
mice without P. gingivalis treatment, P. gingivalis 
LPS suppressed the expansion of CD1dhighCD5+ cells 
induced by CD40L (Figure 2c) with an increase of IL-
10 secretion (Figure 4c). These results suggest that P. 
gingivalis LPS stimulation has different effects on innate 
and adaptive immune responses, and it may enhance 
the IL-10 secretion from fewer CD1dhighCD5+ B cells with 
higher competence or from increased B10 cells other 
than CD1dhighCD5+ cell subset. These differences and 
possible mechanisms need to be investigated in future 
studies. Porphyromonas gingivalis synthesizes two LPS, 
O-LPS and A-LPS. The structures of the O-PS and A-PS 
repeating units, the core oligosaccharide (OS), and the 
A-LPS have been extensively studied24. Analysis of the 
detailed structure of P. gingivalis LPS is essential for 
further mechanistic investigation of the antigenicity of 
this important periodontal pathogen.
P. gingivalis induces periodontitis through the 
disruption of the host tissue homeostasis and adaptive 
immune response, which allows uncontrolled growth of 
the commensal microbial community in oral cavity5,10. 
In our study, P. gingivalis alone showed no effect 
on expansion or reduction of CD1dhighCD5+ cells in B 
cells from both immunized and non-immunized mice. 
However, P. gingivalis
IL-10 secretion in both immunized and non-immunized 
mice B cells, suggesting this induction was caused by 
cells other than CD1dhighCD5+ B cells or by increasing 
the competence of B10 cells in CD1dhighCD5+ subset. 
Furthermore, P. gingivalis treatment significantly 
diminished the CpG-induced IL-10 production (Figures 
4b and 4d) compared with groups without P. gingivalis 
treatment (Figures 4a and 4c) in both innate and 
adaptive immune responses, suggesting that the IL-10 
secretion induced by TLR9 signaling may be inhibited 
by components of P. gingivalis. The mechanism of how 
P. gingivalis induces IL-10 secretion and inhibits TLR9 
signaling induced IL-10 secretion in splenocytes B cell 
needs to be further investigated.
Conclusions
With CD40L, P. gingivalis LPS enhanced IL-10 
competency of B10 cells and B10 cell expansion in 
the absence, but not in the presence of P. gingivalis; 
however, CpG induced the stronger IL-10 competency 
of B10 cells but inhibited B10 expansion under the 
same conditions.
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